Xmab 500 mg Injection
  1. Home
  2. Pharma Products
  3. RPG Life Sciences Ltd
  4. Xmab 500 mg Injection

Xmab 500 mg Injection

Xmab 500 mg Injection contains rituximab 500 mg, a monoclonal antibody used for certain blood cancers and autoimmune disorders. It targets CD20-positive B cells and helps reduce abnormal B-cell activity. The medicine is administered by intravenous infusion under the supervision of a healthcare professional.

BUY NOW

Category

Rituximab binds to the CD20 antigen on B cells and promotes their elimination through immune-mediated mechanisms. Xmab is used in treatment regimens for conditions including non-Hodgkin lymphoma, chronic lymphocytic leukaemia, rheumatoid arthritis, and certain vasculitis disorders. The 500 mg presentation contains rituximab 500 mg in a 50 mL vial, providing a concentration of 10 mg/mL. Xmab 500 mg Injection is manufactured by RPG Life Sciences Ltd and requires refrigerated storage at 2°C–8°C.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 500 mg
Concentration 10 mg/mL
Pack Size 50 mL vial
Dosage Form Injection
Manufacturer RPG Life Sciences Ltd

Product Also Known As

Xmab 500 mg Injection, Xmab 500 mg/50 mL, X-Mab 500 Injection, Xmab Rituximab Injection, Rituximab 500 mg Injection, Rituximab 500 mg/50 mL